#153251

DOK Cell Line

Cat. #153251

DOK Cell Line

Cat. #: 153251

Unit size: 1x10^6 cells / vial

Availability: 10-12 weeks

Organism: Human

Tissue: Tongue

Disease: Cancer

Model: Tumour cell line

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Sidney Chang

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: DOK Cell Line
  • Alternate name: dysplastic oral keratinocyte
  • Cancer: Head and neck cancer
  • Cancers detailed: Human Caucasian dysplastic oral keratinocyte
  • Research fields: Cancer;Drug development
  • Organism: Human
  • Tissue: Tongue
  • Disease: Cancer
  • Growth properties: Adherent
  • Model: Tumour cell line
  • Conditional: Yes
  • Description: DOK (dysplastic oral keratinocyte) cell line was isolated from a piece of dorsal tongue from a 57 year old man (who was a heavy smoker). The degree of dysplasia in the patient was described as mild to moderate. The cells show some stratification in confluent cultures and contain a keratin profile similar to the original dysplasia. Growth is stimulated by hydrocortisone and inhibited by cholera toxin. Expression of p53 is increased and a 12 bp in-frame deletion of the p53 gene (codon 188-191) could be identified. DOK cells are non-tumourigenic in athymic nude mice. This cell line can be used to study carcinogens associated with tobacco and their implications in malignant transformation.
  • Application: Study of oral keratinocytes, multi-stage oral carcinogenesis
  • Production details: The dysplastic oral keratinocyte cell line DOK was isolated from a piece of dorsal tongue from a 57 year old man. After a squamous-cell carcinoma was removed from the patient, who had been a heavy smoker, the remaining dysplasia was removed subsequently and used to initiate primary cultures leading to the establishment of DOK.
  • Additional notes: STR-PCR Data: Amelogenin: X,Y CSF1PO: 12 D13S317: 11,13 D16S539: 9,12 D5S818: 12 D7S820: 11,13 THO1: 6,8 TPOX: 10 vWA: 14,18
  • Cellosaurus id: CVCL_1180

Applications

  • Application: Study of oral keratinocytes, multi-stage oral carcinogenesis
  • Application notes: STR-PCR Data: Amelogenin: X,Y CSF1PO: 12 D13S317: 11,13 D16S539: 9,12 D5S818: 12 D7S820: 11,13 THO1: 6,8 TPOX: 10 vWA: 14,18

Handling

  • Format: Frozen
  • Growth medium: DMEM + 2mM Glutamine + 5ug/ml Hydrocortisone + 10% Foetal Bovine Serum (FBS).
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice
  • Subculture routine: Split sub-confluent cultures (70-80%) 1:10 i.e. seeding at 2-4x10,000 cells/cm² using 0.05% trypsin or trypsin/EDTA; 5% CO₂; 37°C.

References

  • Burns et al. 1994. Br J Cancer. 70(4):591-595. PMID: 7917902.
  • Chang et al. 1992. Int J Cancer. 52(6):896-902. PMID: 1459732.